A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Genital Psoriasis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
The main purpose of this study is to evaluate the efficacy and safety of the study drug ixekizumab compared to placebo in participants with moderate-to-severe genital psoriasis.
Epistemonikos ID: de0ac2f2b4741f002a53276491a17ff5bc75b865
First added on: May 12, 2024